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 Low-level laser (light) therapy (LLLT) has been known since 1967 but still remains
controversial due to incomplete understanding of the basic mechanisms and the selection
of inappropriate dosimetric parameters that led to negative studies. The biphasic dose-
response or Arndt-Schulz curve in LLLT has been shown both in vitro studies and in ani-
mal experiments. This review will provide an update to our previous (Huang et al. 2009)
coverage of this topic. In vitro mediators of LLLT such as adenosine triphosphate (ATP)
and mitochondrial membrane potential show biphasic patterns, while others such as mito-
chondrial reactive oxygen species show a triphasic dose-response with two distinct peaks.
The Janus nature of reactive oxygen species (ROS) that may act as a beneficial signaling
molecule at low concentrations and a harmful cytotoxic agent at high concentrations, may
partly explain the observed responses in vivo. Transcranial LLLT for traumatic brain
injury (TBI) in mice shows a distinct biphasic pattern with peaks in beneficial neurologi-
cal effects observed when the number of treatments is varied, and when the energy den-
sity of an individual treatment is varied. Further understanding of the extent to which
biphasic dose responses apply in LLLT will be necessary to optimize clinical treatments.
Keywords: low level laser therapy, photobiomodulation, biphasic dose response, reactive oxygen species,
nitric oxide, traumatic brain injury
INTRODUCTION
Low level laser (light) therapy (LLLT) employs visible (generally red)
or near-infrared light generated from a laser or light emitting diode
(LED) system to treat diverse injuries or pathologies in humans or ani-
mals. The light is typically of narrow spectral width between 600nm -
1000nm. The fluence (energy density) used is generally between 1 and 20
J/cm2 while the irradiance (power density) can vary widely depending on
Address correspondence to Prof. Michael R. Hamblin, BAR414, Massachusetts General
Hospital, 40 Blossom Street, Boston, MA 02114; Ph: 617-726-6182; Fax:617-726-8566; email:
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the actual light source and spot size; values from 5 to 50 mW/cm2 are
common for stimulation and healing, while much higher irradiances (up
to W/cm2) can be used for nerve inhibition and pain relief. LLLT is typ-
ically used to promote tissue regeneration, reduce swelling and inflam-
mation and relieve pain and is often applied to the injury for 30 seconds
to a few minutes or so, a few times a week for several weeks. Unlike other
medical laser procedures, LLLT is not an ablative or thermal mechanism,
but rather a photochemical effect comparable to photosynthesis in plants
whereby the light is absorbed and exerts a chemical change.
Within a decade of the introduction of LLLT in the 1970s it was real-
ized that more does not necessarily mean better. The demonstration of
the biphasic dose response curve in LLLT has been hampered by dis-
agreement about exactly what constitutes a “dose”. Many practitioners
concentrate on fluence as the principle metric of dose, while others pre-
fer irradiance or illumination time. The use of very small spot sizes by
some practitioners has led to the assertion that they delivered hundreds
of mW/cm2 from a 50 mW laser. While this statement is mathematically
correct it can give the impression that much higher doses of light were
given than actually were delivered.
Two years ago we reviewed (Huang et al. 2009) the biphasic dose
response in LLLT and found many reports in the literature concerning
biphasic dose responses observed in cell cultures, some in animal exper-
iments but no clinical reports. We now believe that the time is right to
revisit this interesting topic for two reasons. Firstly because we have found
more instances in our laboratory both in vitro with cultured cortical neu-
rons, and in vivo with LLLT of traumatic brain injuries in mouse models.
Secondly because advances have been made in mechanistic understand-
ing of how LLLT works at a cellular level that may explain why a little light
may be beneficial and at the same time a lot of light might be harmful.
MECHANISMS OF LOW LEVEL LIGHT THERAPY.
Basic photobiophysics and photochemistry
According to the First Law of Photochemistry, the photons of light
must be absorbed by some molecular photoacceptors or chromophores
for photochemistry to occur (Sutherland 2002).The mechanism of LLLT
at the cellular level has been attributed to the absorption of monochro-
matic visible and near infrared (NIR) radiation by components of the cel-
lular respiratory chain (Karu 1989). Phototherapy is characterized by its
ability to induce photobiological processes in cells. The effective tissue
penetration of light and the specific wavelength of light absorbed by pho-
toacceptors are two of the major parameters to be considered in light
therapy. In tissue there is an “optical window” that runs approximately
from 650 nm to 1200 nm where the effective tissue penetration of light is
Biphasic Dose Response in LLLT – An Update
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maximized. Therefore the use of LLLT in animals and patients almost
exclusively involves red and near-infrared light (600-1100-nm) (Karu and
Afanas’eva 1995). The action spectrum (a plot of biological effect against
wavelength) shows which specific wavelengths of light are most effective-
ly used for biological endpoints as well as for further investigations into
cellular mechanisms of phototherapy (Karu and Kolyakov 2005). Fluence
(J/cm2) is often referred to as “dose”, though many authors and practi-
tioners of LLLT also refer to energy (Joules) as dose. Not only is this con-
fusing to the novice student of LLLT but it also assumes that the product
of power and time (and more importantly power density and time) is the
goal rather than the right combination of individual values. This lack of
reciprocity has been shown many times before and since our first paper
on biphasic dose response and several more authors have reported find-
ing these effects since. Examples of recently published “dose-rate” effects
are also reviewed later in this article.
Mitochondrial Respiration and Cytochrome c oxidase
Mitochondria play an important role in energy generation and
metabolism and are involved in current research about the mechanism of
LLLT effects. The absorption of monochromatic visible and NIR radia-
tion by components of the cellular respiratory chain has been considered
as the primary mechanism of LLLT at the cellular level (Karu 1989).
Cytochrome c oxidase (Cco) is proposed to be the primary photoaccep-
tor for the red-NIR light range in mammalian cells. Absorption spectra
obtained for biological responses to light were found to be very similar to
the absorption spectra of Cco in different oxidation states (Karu and
Kolyakov 2005).LLLT on isolated mitochondria increased proton elec-
trochemical potential, ATP synthesis (Passarella et al. 1984), increased
RNA and protein synthesis (Greco et al. 1989) and increases in oxygen
consumption, mitochondrial membrane potential, and enhanced synthe-
sis of NADH and ATP.
ROS release and Redox signaling pathway
Mitochondria are an important source of reactive oxygen species
(ROS) within most mammalian cells. Mitochondrial ROS may act as a
modulatable redox signal, reversibly affecting the activity of a range of
functions in the mitochondria, cytosol and nucleus. ROS are very small
molecules that include oxygen ions such as superoxide, free radicals such
as hydroxyl radical, hydrogen peroxide, and organic peroxides. ROS are
highly reactive with biological molecules such as proteins, nucleic acids
and unsaturated lipids. ROS are also involved in the signaling pathways
from mitochondria to nuclei. It is thought that cells have ROS or redox
sensors whose function is to detect potentially harmful levels of ROS that
Y-Y. Huang and others
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may cause cell damage, and then induce expression of anti-oxidant
defenses such as superoxide dismutase and catalase.
LLLT was reported to produce a shift in overall cell redox potential
in the direction of greater oxidation (Karu 1999) and increased ROS gen-
eration and cell redox activity have been demonstrated (Lubart et al.
2005). These cytosolic responses may in turn induce transcriptional
changes. Several transcription factors are regulated by changes in cellular
redox state, but the most important one is nuclear factor κB (NF-κB).
Figure 1 graphically illustrates some of the intracellular signaling path-
ways that are proposed to occur after LLLT.
NO release and NO signaling
There have been reports of the production and/or release of NO
from cells after in vitro LLLT. It is possible that the delivery of low flu-
ences of red/NIR light produces a small amount of NO from mitochon-
dria by dissociation from intracellular stores (Shiva and Gladwin 2009),
such as nitrosothiols (Borutaite et al. 2000), NO bound to hemoglobin or
myoglobin (Lohr et al. 2009; Zhang et al. 2009) or by dissociation of NO
from Cco (Lane 2006) as depicted in Figure 2. A second mechanism for
Biphasic Dose Response in LLLT – An Update
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FIG. 1. Schematic depiction of the cellular signaling pathways triggered by LLLT. After photons are
absorbed by chromophores in the mitochondria, respiration and ATP is increased but in addition sig-
naling molecules such as reactive oxygen species (ROS) and nitric oxide (NO) are also produced. 
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NO production is by light-mediated increase of the nitrite reductase activ-
ity of cytochrome c oxidase (Lane 2006). A third possibility is that light
can cause increase of the activity of an isoform of nitric oxide synthase
(Poyton and Ball 2011), possibly by increasing intracellular calcium lev-
els. This low concentration of NO produced by illumination is proposed
to be beneficial through cell-signaling pathways (Ball et al. 2011).
BIPHASIC DOSE RESPONSES IN LLLT
Many reports of biphasic dose responses in LLLT were reviewed in
our previous contribution and for convenience we have assembled these
reports into Tables. Table 1 lists reports on cultured cells in vitro, Table 2
lists those reports in animal models in vivo, while Table 3 contains the
only report of biphasic dose response in clinical studies.
Figure 3 shows a 3D depiction of the Arndt Schulz model to illustrate
a possible dose “sweet spot” at the target tissue. This graph suggests that
insufficient power density or too short a time will have no effect on the
pathology, that too much power density and / or time may have inhibito-
ry effects and that there may be an optimal balance between power den-
sity and time that produces a maximal beneficial effect. There even may
be a (low) power density for which infinite irradiation time would only
have positive effects and no inhibitory effect. We believe that the absolute
figures will be different at different wavelengths, tissue types, redox states,
and may be affected further by different pulse parameters.
Y-Y. Huang and others
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FIG. 2. One possible theory that can explain the simultaneous increase in respiration an production
of nitric oxide is the photodissociation of bound NO that is inhibiting cytochrome c oxidase by dis-
placing oxygen. 
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CURRENT BIPHASIC DOSE RESPONSE STUDIES IN LLLT.
In this section we cover the new reports of biphasic dose responses in
LLLT that have been published in the last two years since our previous
review.
In an oral mucositis hamster model Lopes and coworkers (Lopes et al.
2009) delivered 660-nm laser at two different irradiances (55 mW/cm2
for 16 seconds per point or 155 mW/cm2 for 6 seconds per point). Both
regimens delivered 0.9 J/cm2 per point. On day 7, 11 and 15 the authors
reported reduced severity of clinical mucositis and lower levels of COX-2
staining in the 55 mW/cm2 group and that the 155 mW/cm2 had no sig-
nificant differences when compared with controls. This data is summa-
rized in Figure 4.
Gal et al (Gal et al. 2009) compared the effects of delivering 5 J/cm2
of 670-nm laser at different power densities on wound tensile strength in
a rat model. They found (Figure 5) that 670 nm laser achieved a signifi-
cant effect using 4mW/cm2 applied for 1,250 seconds (20 mins 50 sec-
onds) but that this effect was lost if the same 5J/cm2 fluence was delivered
at 15 mW/cm2 for 333 seconds (5 mins 33 seconds).
(Skopin and Molitor 2009) studied the effects of different influences
of 980 nm laser on a human fibroblast in vitro model of wound healing.
Biphasic Dose Response in LLLT – An Update
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FIG. 3. Three-dimensional model of the Arndt-Schulz curve illustrating how either irradiance or illu-
mination time (fluence) can have biphasic dose response effects in LLLT. 
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A small pipette was used to induce a wound in fibroblast cell cultures,
which were exposed to a range of laser doses (1.5-66 J/cm2). Exposure to
low- and medium-dose laser light accelerated cell growth, whereas high-
intensity light negated the beneficial effects of laser exposure as shown in
Figure 6.
(Prabhu et al. 2010) performed a dose response study by applying a 7
mW HeNe (632.8-nm) laser with a power density of 4 mW/cm2 to 15×15
mm excisional wounds on Swiss albino mice for a range of irradiation
times from 249 seconds (4.15 mins) up to 2,290 seconds (41.46 mins). As
Y-Y. Huang and others
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FIG. 4. Mean grading of oral mucositis (OM) in a hamster cheek pouch model treated with 0.9 J/cm2
of 660-nm laser at two different irradiances (55 mW/cm2 for 16 seconds per point or 155 mW/cm2
for 6 seconds per point). Graph redrawn from data contained in (Lopes, Plapler et al. 2009). 
FIG. 5. Mean wound tensile strength obtained after delivering 5 J/cm2 of 670-nm laser at different
power densities (4mW/cm2 applied for 1,250 seconds or 15 mW/cm2 for 333 seconds). Graph
redrawn from data contained in (Gal, Mokry et al. 2009). 
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Figure 7 shows, there was a clear biphasic response (including a possible
inhibitory effect) with changes in irradiation time and therefore fluence.
BIPHASIC LLLT DOSE RESPONSE STUDIES IN CULTURED NEURONS
AND TRAUMATIC BRAIN INJURY MODELS IN MICE.
LLLT studies on cultured cortical neurons
In order to elucidate the mechanism responsible for the beneficial
effect reported by LLLT for brain related disorders, we carried out stud-
Biphasic Dose Response in LLLT – An Update
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FIG. 6. Mean percentage of healing induced in a scratch wounded culture of human fibroblasts using
different fluences (constant time, increasing irradiance) of 980-nm laser. Graph redrawn from data
contained in (Gal, Mokry et al. 2009). 
FIG. 7. Mean area under the curve of wound area over time in a mouse excisional wound healing
model treated with a 7 mW (power density of 4 mW/cm2) HeNe (632.8-nm) laser for times ranging
from 249 to 2,290 seconds. Graph redrawn from data contained in (Prabhu, Rao et al. 2010). 
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ies to look into effects of 810 nm laser on different cellular signaling mol-
ecules in primary cortical neurons. The primary cortical neurons were
isolated from brains taken from embryonic mice. We irradiated the neu-
rons with different fluences of 0.03, 0.3, 3, 10 or 30 J/cm2 delivered at a
constant irradiance of 25 mW/cm2, and subsequently the intracellular
levels of ROS, mitochondrial membrane potential (MMP) and ATP was
measured. The changes in mitochondrial function were studied in terms
of ATP and MMP. Low-level light was found to induce a significant
increase in ATP and MMP at lower fluences and a decrease at higher flu-
ence. ROS was induced significantly by light at all light doses but there
was a distinctive pattern of a double peak with the first peak coinciding
with the other peaks of ATP and MMP at 3 J/cm2 (Figure 8). However in
contrast to ATP and MMP there was a second larger rise in ROS at 30
J/cm2 that coincided with the reduction in MMP below baseline. The
results of the this study suggested that LLLT at lower fluences is capable
of inducing mediators of cell signaling process which in turn may be
responsible for the biomodulatory effects of the low level laser.
Conversely at higher fluences beneficial mediators are reduced but
potentially harmful mediators are increased. Thus this study offered an
explanation for the biphasic dose response induced by LLLT.
LLLT in a mouse model of traumatic brain injury.
We have been studying the effect of transcranial laser (810-nm) on
mouse models of traumatic brain injury. The model involves a controlled
cortical impact using a pneumatic piston device through a craniotomy
followed by closure of the head. This injury can be adjusted in severity to
Y-Y. Huang and others
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FIG. 8. Mean expression levels of reactive oxygen species (ROS, measured by MitoSox red fluores-
cence), mitochondrial membrane potential (MMP, measured by red/green fluorescence ration of JC1
dye) and ATP (measured by firefly luciferase assay) in primary mouse cortical neurons treated with
various fluences of 810-laser delivered at 25 mW/cm2 over times varying from 1.2 to 1200 seconds. 
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produce a neurological severity score (NSS based on a panel of standard-
ized behavioral tests) of 7-8 on a scale of 0 (normal mice) to 10 (severe
brain injury that causes death). The basic finding was that delivering a
single dose of 36 J/cm2 810-nm laser delivered at 50 mW/cm2 (12 min-
utes illumination time) in a spot of 1-cm diameter centered on the top of
the mouse head at a time point of 4 hours post-TBI was highly effective
in ameliorating the neurological symptoms suffered by the mice
(Figure 9A). When we delivered 10 times as much 810-nm laser (360
J/cm2 at 500 mW/cm2) also taking 12 minutes the beneficial effect total-
ly disappeared, and at early time points (1-6 days) the high fluence
appeared to be worse than no treatment (Figure 9B).
When we repeated the effective laser treatments 14 times (36 J/cm2
delivered at 50-mW/cm2 once a day for 14 days starting 4 hours post-TB)
we found a very interesting result (Figure 9C). For the first 4 days the
improvement in NSS in the repeated laser group was marginally better
than the single treatment. However on day 5 the gradual improvement
ceased and as the laser was repeated the NSS got closer to that of untreat-
ed TBI mice until at day 14 it actually crossed over. Although the differ-
ences were not statistically significant it appeared that from day 16 until
day 28 the mice that received 14 laser treatments did worse than those
that received no treatment at all.
POSSIBLE EXPLANATIONS FOR BIPHASIC DOSE RESPONSE IN LLLT
The triphasic dose response we have observed for ROS production in
cultured cortical neurons (see Fig 7) suggests an explanation for the
biphasic dose response. The hypothesis is that there are two kinds of
ROS. Good ROS are produced at fairly low fluences of light. The reason
for the production of good ROS is likely to be connected with stimulation
of mitochondrial electron transport as shown by increases in MMP and
increases in ATP production. These good ROS can initiate beneficial cell
signaling pathwas leading to activation of redox sensitive transcription
factors such as NF-κB (Chandel et al. 2000; Groeger et al. 2009). NF-κB
activation induces expression of a large number of gene products related
to cell proliferation and survival (Karin and Lin 2002; Brea-Calvo et al.
2009). As the fluence of light is increased the beneficial ROS production
in the mitochondria decreases in tandem with reductions in MMP and a
drop-off in ATP production. Then when even more light is delivered
there is a second peak in ROS production, which we will call bad ROS.
Bad ROS can damage the mitochondria leading to a drop in MMP below
baseline levels and presumably can lead to initiation of apoptosis by the
mitochondrial pathway including cytochrome c release. It remains to be
seen whether the good and bad ROS are identical species and just differ
in amount, or whether they are chemically different species. For instance
it may be hypothesized that the good ROS consists mainly of superoxide
Biphasic Dose Response in LLLT – An Update
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FIG. 9. Transcranial laser therapy (36 J/cm2 of 810-nm laser delivered at 50 mW/cm2 (12 minutes
illumination time) in a spot of 1-cm diameter centered on the top of the mouse head) was used to
treat mice with controlled cortical impact TBI four hours after injury. (A) Significant improvement
in neurological severity score continuing for 4 weeks after a single treatment. (B) Delivering ten
times more light by increasing irradiance tenfold (500 mW/cm2) loses all therapeutic benefit, and
produces worse performance soon after laser. (C) Repeating beneficial laser treatment daily for 14
days loses benefit in performance after 5 days. 
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while the bad ROS consists of more damaging ROS such as hydroxyl rad-
icals and peroxynitrite. In Figure 7 we used just one type of fluorescent
ROS indicator (mitoSOX red), which is commonly supposed to be spe-
cific for superoxide but will likely also be activated by hydroxyl radicals
and peroxynitrite.
There have been several studies showing that relatively high doses of
light can induce apoptosis in various cell types via ROS-mediated signal-
ing pathways (Huang et al. 2011). Meanwhile, there is an important
proapoptotic signaling pathway has been identified which involves
Akt/GSK3beta inactivation after high-fluence low-power laser irradiation
(HF-LPLI) (Huang, Wu et al. 2011). This research extended the knowl-
edge of the biological mechanisms of cytotoxicity induced by HF-LPLI. In
one of the studies it was shown that HF-LPLI does not activate caspase-8,
indicating that the induced apoptosis was initiated directly from mito-
chondrial ROS generation and a decrease in MMP, independent of cas-
pase-8 activation (Wu et al. 2007). Another study revealed HF-LPLI
induced cell apoptosis via the CsA-sensitive MPT, which was ROS-depend-
ent. They also showed a secondary signaling pathway through Bax activa-
tion. It was concluded that link between MPT and triggering ROS could
be a fundamental phenomenon in HF-LPLI-induced cell apoptosis (Wu
et al. 2009).
Further work is necessary to fully elucidate the molecular and cellu-
lar mechanisms responsible for the biphasic dose response in LLLT.
Besides the role of ROS, which we have discussed above, the role of
another Janus-type mediator, nitric oxide (NO) may play a role. If high
fluences of light could produce high concentrations of NO, this might
result in cytotoxicity via formation of peroxynitrite or other reactive nitro-
gen species (Hirst and Robson 2010).
SUMMARY AND CONCLUSION
The number of instances of biphasic dose response reported in the
LLLT literature is increasing as time progresses. This increase may be due
to an increasing realization that the phenomenon is real, and thus
prompting investigators to look for it. At present there has been no con-
vincing report of biphasic dose responses occurring in patients, but sev-
eral systematic reviews and meta analyses of randomized controlled trials
in LLLT have found (Bjordal et al. 2003; Tumilty et al. 2009) that some
ineffective trials may be explained by over-dosing, in that the guidelines
set by World Association for Laser Therapy (www.walt.nu) were exceeded.
As more clinical trials of LLLT are reported there is an increasing likeli-
hood that this unfortunate state of affairs will continue unless the dosime-
try is designed to take into account the biphasic dose response phenom-
enon. Moreover it is unknown to what extent the parameters needed for
the onset of the biphasic dose response will vary in a highly heteroge-
Biphasic Dose Response in LLLT – An Update
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neous patient population, as compared with a highly uniform population
of experimental animals (inbred lab animals are genetically identical).
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